Trial Profile

A bridging clinical trial of Uni-PTH

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 14 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Teriparatide (Primary)
Indications Osteoporosis
Focus Adverse reactions
Sponsors Uni-Bio Science Group

Most Recent Events

14 Oct 2021 New trial record
04 Sep 2021 According to a Uni-Bio Science Group media release, the National Medical Products Administration (NMPA) has approved clinical trial application for Uni-PTH bridging studies with the acceptance number of CXSL2000138. These bridging clinical trials, will accelerate the launch of Uni-PTH, expected as soon as 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com